drugset / Trial / NCT06250400
Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to study patients with chronic spontaneous urticaria. The main question it aims to answer is the efficacy and safety of histamine human immunoglobulin (ShuYangMinNing) in the treatment of chronic spontaneous urticaria.
Timeline
- Start
- 2024-03-31
- Primary completion
- 2025-07-01
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Histamine Human Immunoglobulin | Unknown | 12 mg | Subcutaneous |
| Background | Loratadine | Small molecule | 10 mg | Oral |